AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $19,919,000 | -45.8% | 3,852,871 | -0.2% | 0.00% | -40.0% |
| Q4 2015 | $36,738,000 | +15.9% | 3,858,999 | +0.3% | 0.01% | 0.0% |
| Q3 2015 | $31,695,000 | -49.0% | 3,846,483 | +0.6% | 0.01% | -37.5% |
| Q2 2015 | $62,109,000 | -58.2% | 3,824,438 | +4.2% | 0.01% | -57.9% |
| Q1 2015 | $148,720,000 | -18.3% | 3,670,276 | +8.9% | 0.02% | -20.8% |
| Q4 2014 | $181,939,000 | +59.5% | 3,369,245 | +1.0% | 0.02% | +60.0% |
| Q3 2014 | $114,102,000 | – | 3,337,292 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|